Martin Turner

Martin Turner is a Research Fellow at the University of Cambridge, affiliated with the Cambridge Stem Cell Institute and Immunology Programme. His work focuses on post-transcriptional gene regulation in lymphocytes.

• First systematic application of molecular biology to cytokine gene expression in human immune cells
• Defined phosphoinositide 3-kinase roles in lymphocyte development
• Instrumental in microRNA-155 biology research
• Developed cutting-edge methods like iCLIP and ribosome profiling

His research combines mouse genetics with multiomics to study RNA binding proteins' regulatory roles in B-cell diseases and immune responses. Collaborative work with ICOS Corporation established PI3K inhibition rationale.

• 2016 Wellcome Investigator awardee
• 2007 MRC Senior Non-Clinical Fellowship recipient
• 2005 Research Council Individual Merit promotion

Publications reveal expertise in RNA-protein interactions and lymphocyte signaling pathways, with recent work on translational control and multi-omics integration. Leads a team of 12 researchers including PhD students and postdocs at The Babraham Institute.